Navigation Links
Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
Date:10/30/2007

New robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting

ROYAL OAK, Mich., Oct. 30 /PRNewswire/ -- Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse(TM), the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

Since 2006, Beaumont Hospital has been running a successful intracranial radiosurgery program with Leksell Gamma Knife, and the hospital now is expanding its stereotactic treatment offerings to all parts of the anatomy.

"We chose Elekta Axesse because of its versatility," says Alvaro Martinez, M.D., F.A.C.R., corporate chairman, Radiation Oncology, Beaumont Hospitals. "We now can stereotactically treat both intra- and extra-cranial lesions, and the 6D robotically-controlled tabletop gives us the freedom to position the patient at virtually any angle. This enables a much more accurate and precise treatment for these lesions than we could provide in the past."

Integrating advanced technology and software to elevate the patient experience, streamline clinician workflow

The advanced 3D imaging capabilities of Elekta Axesse facilitate rapid, precise targeting of tumors, and the highly-conformal radiation delivery system effectively treats tumors while minimizing damage to patients' healthy tissue.

"Elekta Axesse enables us to attain sub-millimeter accuracy by planning in 3D and imaging patients in 3D prior to treatment, every day," says Dr. Martinez.

Elekta Axesse also integrates non-invasive patient immobilization to ensure patients properly
'/>"/>

SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Currently offering a comprehensive portfolio ... Weighing, Rice Lake, and Ohaus, Pipette.com has added ... Sartorius CPA Semi-Micro Balance is ideal for lab ... user-friendly laboratory balance. , Sartorius is a global ... balances are well known for their high performance, ...
(Date:10/22/2014)... VANCOUVER , Oct. 22, 2014 /PRNewswire/ - iCo ... ICOTF), today announced next steps for its Oral ... findings from its in vitro work ... therapy.  iCo now plans to complete pre clinical ... an initial Phase 1A clinical trial, utilizing approximately ...
(Date:10/20/2014)... 2014 Mapp Biopharmaceutical,s valiant effort to ... to fight the Ebola outbreak will make the ... production of pharmaceuticals can be, according to Kalorama ... while some may be taken aback by the ... industry knowledge are well aware of the complex ...
(Date:10/20/2014)... GAITHERSBURG, Md. , Oct. 20, 2014  GenVec, Inc. ... Zola P. Horovitz , Ph.D., from its board of ... GenVec board in August 2003, and served as its chairman ... also served on the Nominating and Corporate Governance and Audit ... Zola for more than a decade of dedicated service to ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Zola P. Horovitz To Retire From GenVec Board 2
... March 16 Micromet, Inc. (Nasdaq: MITI ), ... of cancer, inflammation and autoimmune diseases, today announced the publication ... meeting of AACR taking place from April 20-24, 2009, in ... , Lutterbuese, ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) ... of innovative therapeutic products for the treatment of cancer, ... a notice from the NASDAQ Hearings Panel that Oncothyreon ... of The NASDAQ Global Market. , The notice followed ...
... take two bricks and place them side by side a ... the bricks will be covered with snow and barely discernible. ... around the bricks. , What you will see, says Ivan ... smallest of scales on an integrated optical circuit, could hasten ...
Cached Biology Technology:Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 2Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 3Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 4Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 5Oncothyreon regains compliance with NASDAQ listing requirements 2New organic material may speed Internet access 2New organic material may speed Internet access 3New organic material may speed Internet access 4New organic material may speed Internet access 5
(Date:10/15/2014)... have linked increased resistance to bacterial pneumonia in female ... hormone estrogen. , Females are naturally more resistant to ... scientists has shown that increased resistance to bacterial pneumonia ... oxide synthase 3 (NOS3). They also show that this ... female sex hormone estrogen. , The team, lead by ...
(Date:10/15/2014)... be awarded the 44th Rosenstiel Award for Distinguished Work ... research exploring the mechanisms of genomic instability and its ... is the second alumnus to win the Rosenstiel Award; ... 2003. , Alt is the Charles A. Janeway Professor ... School and an investigator at the Howard Hughes Medical ...
(Date:10/14/2014)... thieves, prostate cancer tumors scavenge and hoard copper that ... avarice may be a fatal weakness. , Researchers ... prostate cancer cells by delivering a trove of copper ... cells brimming with the mineral, leaving non-cancer cells healthy. ... commercially available for other uses, could soon be tested ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Prostate cancer's penchant for copper may be a fatal flaw 2
... MANHATTAN, KAN. -- New findings about the causes of ... genetic. "We now know it,s also in the ... Professor of Diagnostic Medicine and Pathobiology at Kansas State ... ago, Richt said, it was thought that the cattle ...
... Neurons constituting the optic nerve wire up to the ... developing retina sprout processes, called axons, which extend toward visual ... U-turns when they take the wrong path. How they find ... Using the mouse visual system, a team of Salk ...
... CITY After years of working toward this goal, scientists ... isolate cancer stem cells in tumors so they can target ... A research team at the University of Oklahoma led ... a particular protein only appears in stem cells. Until now, ...
Cached Biology News:K-State professor's USDA research shows mad cow disease also caused by genetic mutation 2A second career for a growth factor receptor: keeping nerve axons on target 2A second career for a growth factor receptor: keeping nerve axons on target 3
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
p-Raf-1 (Ser 338/Tyr 341)-R...
Rabbit polyclonal to Syntrophin alpha 1 ( Abpromise for all tested applications). entrezGeneID: 6640 SwissProtID: Q13424...
Biology Products: